Canada Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
122 Pages - SKU: BMI5325544
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Canada will continue to attract pharmaceutical companies to launch innovative medicines dueto the hospitable business environment, improving healthcare coverage and broader drug reimbursementlists. The regulatory authority also encourages pharmaceutical companies to invest in research anddevelopment. However, cost containment policies in the public healthcare sector will continue to putpressure on Canada's medicine prices.

Headline Expenditure Projections

Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.9bn (USD22.5bn) in 2014; +0.8% inlocal currency terms and -9.7% in US dollar terms. Forecast unchanged from Q314.

More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Canada Prescription Drugs reports

Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
Pharmaceuticals in Canada: ISIC 2423 by Euromonitor International
Pharmaceuticals in Canada: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>



    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!